Marquis Who’s Who Honors Susan S. Feury for Expertise in Health Care and Technology
Susan S. Feury has also been honored for her expertise in marketing and strategy consulting
STONEHAM, MA, February 02, 2025 /24-7PressRelease/ — Susan S. Feury has been selected for inclusion in Marquis Who’s Who. As in all Marquis Who’s Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Ms. Feury stands out as a seasoned professional with a diverse background in health care and technology. Serving as the founder and managing director at Voxcellerate LLC since 2021, she brings a wealth of experience to her role. Prior to this appointment, Ms. Feury was the chief of staff for the Therapeutic Solutions Division at Olympus Corporation of the Americas from 2022 to 2023, where she played a pivotal role in strategic planning and operations. Her expertise was also honed at Cytel, where she served as the global head of product marketing management from 2019 to 2021.
Ms. Feury’s tenure at GE Healthcare is particularly notable, where she progressed from America’s product marketing manager between 2011 and 2013 to senior product marketing manager between 2013 and 2019 for Centricity Practice Solution. It was here that she made significant contributions to revenue growth and market share retention amid fierce competition and limited resources. Earlier in her career, Ms. Feury held positions as a product manager at TransMedics from 2010 to 2011, an associate product development manager at Abiomed from 2008 to 2010, and a product manager for pharmaceuticals at Ahura Scientific, Inc. from 2007 to 2008. She also gained valuable experience as a marketing intern at Boston Scientific Corporation in 2006 and as a process engineer III at Biogen Idec from 1999 to 2005.
Building upon her solid foundation in engineering and business, Ms. Feury’s educational background has been instrumental in her professional achievements. Attending Dartmouth College, she earned a Master of Business Administration from The Tuck School of Business in 2007 and a Master of Engineering Management in 1999. Her undergraduate studies at the college culminated with a Bachelor of Engineering in chemical engineering and a Bachelor of Arts in engineering and chemistry in 1998 and 1997, respectively. Additionally, Ms. Feury expanded her knowledge through a Certificate in Artificial Intelligence for Business Strategy from the Massachusetts Institute of Technology.
Ms. Feury’s success can be attributed to her determination, positive attitude, resilience, teamwork skills, creative thinking and innovative approaches that have distinguished her from her peers. Her commitment to excellence was recognized when she received the “Delivers Results in an Uncertain World” Award from GE Healthcare in 2017, serving as a testament to her ability to achieve outstanding outcomes despite challenging circumstances. Beyond her professional endeavors, she is actively involved in supporting the health care industry’s evolution through extracurricular activities. She has served as an Accelerator Health Technology judge for MassChallenge since 2019 and is a founding sponsor of the Digital Therapeutics Alliance. Her commitment to this emerging field is evident through her sponsorship roles at industry events, such as the DTx East Conference.
In addition to her industry contributions, Ms. Feury is dedicated to her community and family life. She volunteers at her daughter’s school and supports her daughter’s gymnastics program by coordinating fundraising efforts during holidays to benefit senior students. Her personal interests also include cooking, gardening and nurturing family bonds. Looking ahead, Ms. Feury aims to leverage her expertise to guide companies through uncertain times within the dynamic health care sector. Her goal is to contribute to the maturity and growth of innovative health care segments that promise significant advancements in patient care.
# # #